Resiliency in BPD Treatment

Why is resiliency important for patients with borderline personality disorder—and the clinicians who treat them?

About 14 million Americans will be diagnosed with borderline personality disorder (BPD) at some point in their lives. In this Mental Health Minute video, Karen L. Jacob, PhD, program director of the Gunderson Residence and assistant professor of psychology in the Harvard Medical School Department of Psychiatry, discusses BPD and how clinicians can integrate resiliency into the treatment process for patients with BPD.

Dr Jacob is program director of the Gunderson Residence, a personality disorders program at McLean Hospital, and an assistant professor of psychology in the Harvard Medical School Department of Psychiatry.

Related Videos
“What we’re striving to do is conquer the unmet needs that are still here with treating ADHD, especially from a medication standpoint.”
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
A new treatment in development is poised to be a game-changer for patients with postpartum depression.
An expert discusses the latest on EndeavorRx and more digital therapeutics for this patient population.
© 2023 MJH Life Sciences

All rights reserved.